2027 Future Talent Program - Data, AI, and Genome Sciences - Intern
Merck
Summary
The Future Talent Program within our Research & Development Division Data, AI, and Genome Sciences (DAGS) Department is offering internships that last 10-12 weeks. We have 1 open position on the AI/ML Data Science, In Silico Perturbation Team. Candidates can apply for the opportunity to be involved in one or more of the projects listed below. The projects are designed to enable students to further develop their skills and to evaluate if we are the right company for their long-term goals. We are seeking highly motivated students with computational skillsets.
Job description
AI/ML Data Science
- Develop statistical and computational methods/pipelines to utilize, analyze, interpret, and validate perturb-seq datasets.
- Develop approaches to assess, interpret, and validate in silico perturbation predictions from single-cell foundation models.
Required Education And Skills
- Must be currently enrolled in a PhD degree in Computer Science, Statistics, Bioinformatics, Computational Biology, or related technical field.
- Must be available to work full-time for 10-12 weeks beginning in May or June of 2027.
- Demonstrated experience with single-cell omics data (e.g., scRNA-seq, perturb-seq).
- Excellent software design and development skills and strong proficiency in Python.
- Excellent communication skills and ability to work collaboratively in a multi-disciplinary team.
Preferred Skills And Experience
- Motivated to impact biological projects with independent project leadership experience.
- Experience with biological foundation models (e.g., single-cell foundation models).
- Experience with advanced statistics and/or Bayesian methods.
- Proficiency in modern ML frameworks (e.g., PyTorch) and experience implementing scalable solutions for complex tasks.
- Publications in journals or conferences.
Requirements
- Currently enrolled in a PhD degree in Computer Science, Statistics, Bioinformatics, Computational Biology, or related technical field
- Available to work full-time for 10-12 weeks beginning in May or June of 2027
- Demonstrated experience with single-cell omics data (e.g., scRNA-seq, perturb-seq)
- Excellent software design and development skills
- Strong proficiency in Python
- Excellent communication skills
- Ability to work collaboratively in a multi-disciplinary team
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.